. Author manuscript; available in PMC: 2019 Nov 14.

Published in final edited form as: Int J Tuberc Lung Dis. 2019 Apr 1;23(4):491–497. doi: 10.5588/ijtld.18.0336

Table A.

Patient-based predictors of SGM (including M. gordonae) vs. RGM respiratory specimens in HIV-infected subjects

	NTM-positive SGM^* (n = 37) %	NTM-positive RGM^† (n = 27) %	P value
Age, years, mean ± SD	45 ± 9	44 ± 8	0.62
CD4 count, cells/mm³, median [IQR]	34 [13–95]	107 [40–162]	0.01
Viral load,^‡, copies/ml median [IQR]	97 622 [2 823–288 346]	97 816 [20 594–190 712]	0.71
cART use	24	26	0.88
On MAC prophylaxis	8	4	0.63
Ever smoker	84	89	0.72
COPD	38	44	0.60
Esophageal reflux	24	7	0.10
Diabetes mellitus	11	15	0.71
Hematocrit, % mean ± SD	34 ± 6	34 ± 7	0.96

MAC, M. kansasii.

^†

M. fortuitum, M. abscessus, M. chelonae.

^‡

Not collected upon hospitalization.

SGM = slow-growing mycobacteria; RGM = rapid-growing mycobacteria; HIV = human immunodeficiency virus; NTM = non-tuberculous mycobacteria; SD = standard deviation; IQR = interquartile range; cART = combined antiretroviral therapy; MAC = M. avium complex; COPD = chronic obstructive pulmonary disease.